GHK-Cu is the copper(II) complex of GHK, a naturally occurring tripeptide with the sequence glycyl-L-histidyl-L-lysine. GHK itself was first isolated from human plasma in 1973, and has since also been identified in saliva and urine. It carries a strong natural affinity for copper ions, and in physiological conditions exists predominantly as the copper-bound complex referred to as GHK-Cu.
Levels of GHK in plasma are reported to decline with age — a pattern that has made it a long-standing subject of research interest in tissue ageing and repair biology, distinct from the angiogenesis-focused or actin-regulation mechanisms seen in peptides like BPC-157 and TB-500.
Primary Mechanism: Copper-Mediated Enzyme Activation
GHK-Cu’s research profile centres on its role in activating copper-dependent enzymes involved in building and remodelling the extracellular matrix (ECM) — the structural scaffold that supports skin, connective tissue, and other organs. Research has also characterised it as acting on gene expression more broadly, with reported influence over genes associated with tissue repair, inflammatory regulation, and antioxidant defence.
This dual role — as both a direct biochemical cofactor and a broader modulator of gene expression — is what distinguishes GHK-Cu’s research literature from single-pathway peptides, and is also why it appears across a notably wide range of research areas, from dermal repair to bone healing to antioxidant biology.
Documented Research Areas
Extracellular Matrix Remodelling
The most extensively characterised area of GHK-Cu research relates to its influence on collagen, elastin, and proteoglycan synthesis in skin and connective tissue models. Research has reported that the peptide can stimulate both the synthesis and the controlled breakdown of these structural proteins, alongside modulation of the matrix metalloproteinases and their inhibitors that govern ECM turnover — consistent with a role in tissue remodelling rather than simple stimulation alone.
Antioxidant and Anti-Inflammatory Signalling
A substantial body of research has examined GHK-Cu’s effects on oxidative stress pathways, with studies reporting increased activity of antioxidant enzymes including superoxide dismutase in treated tissue. Separately, research has reported reduced levels of pro-inflammatory cytokines such as TNF-alpha and IL-6 in models of dermal and lung tissue injury, suggesting a role in modulating the inflammatory phase of tissue repair.
Wound Healing Models
Animal-model research has reported accelerated wound closure and increased collagen, DNA, and glycosaminoglycan content at treated wound sites, in a dose-dependent pattern. Some studies have also reported restored proliferative capacity in fibroblasts following radiation exposure, an area of particular research interest given the relevance to radiotherapy-related tissue damage.
Bone and Connective Tissue Research
A smaller but growing body of research has investigated GHK-Cu in bone healing models, with reported effects on osteoblast attachment and collagen synthesis relevant to bone matrix formation, including in models of ligament reconstruction. This area is comparatively earlier-stage relative to the dermal and wound-healing literature.
GHK’s antioxidant activity extends to a documented capacity to neutralise certain toxins generated during lipid peroxidation, and research has also characterised it as a cell adhesion molecule — meaning it appears to help cells attach to the extracellular matrix, a property relevant to cell migration and proliferation during tissue repair.
What the Research Does Not Establish
GHK-Cu has one of the longer research histories of any peptide discussed on this site — over five decades since its initial isolation — and a correspondingly large literature base. However, the majority of mechanistic and efficacy data still derives from in vitro and animal-model research, with clinical (human) data concentrated specifically in topical dermatological and cosmetic applications, rather than the broader systemic research areas (bone healing, antioxidant defence, gene expression) that remain primarily preclinical.
Researchers should also note that some published sources discussing GHK-Cu are commercially oriented cosmetic or aesthetic-industry publications rather than independent peer-reviewed literature, and should weight source quality accordingly when reviewing claims about this compound.
Sourcing Research-Grade GHK-Cu
Any GHK-Cu used in a laboratory setting should be accompanied by a batch-specific Certificate of Analysis confirming identity, copper content, purity via HPLC analysis, and screening for heavy metals and endotoxins. At Claripep, every batch is independently tested by a third-party laboratory before listing.
This article is provided for research and educational purposes only. It does not constitute medical advice and should not be interpreted as promoting human or veterinary use of this compound. All products supplied by Claripep Ltd are intended strictly for laboratory research applications.
Reference: Pickart L, Margolina A. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” International Journal of Molecular Sciences.